Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997839 · ClinicalTrials.gov registry record · NA
Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02997839: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT02997839 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997839, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The role of sleep in patients admitted to the intensive care unit is an emerging field of research. There have been studies that show patients in the ICU have poor sleep including sleep fragmentation, multiple arousals, decreased stage 3 sleep and reduced REM sleep (1, 2, 3). Causes of poor sleep in the ICU include severity of illness, abnormal light exposure, and frequent arousals for medical care. Not only does poor sleep contribute to reduced cognitive function and delirium, but there are also implications for the immune system function and wound healing (4). Polysomnography is regarded as the gold standard for sleep studies, however it has limited utility in the ICU population (5) and alternative methods of sleep analysis need to be investigated to better understand the underlying physiologic mechanisms and subsequent cognitive effects.
Interventions
- BEHAVIORAL sleep disruption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02997839
The ClinicalTrials.gov registry entry for NCT02997839 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sleep disruption is the first listed.
NCT02997839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02997839 about?
NCT02997839 is a clinical study titled "Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit". The role of sleep in patients admitted to the intensive care unit is an emerging field of research. There have been studies that show patients in the ICU have poor sleep including sleep fragmentation, multiple arousals, decreased stage 3 sleep and reduced REM sleep (1, 2, 3). Causes of poor sleep in...
What is the current status of trial NCT02997839?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-12. Estimated completion is 2018-03-26.
What interventions are being tested in trial NCT02997839?
The interventions under investigation include: sleep disruption (BEHAVIORAL).
Who is sponsoring clinical trial NCT02997839?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.